The Swiss PostASCO Academy Symposium is supported by an unrestricted educational grant from Novartis Pharma Schweiz AG, Janssen-Cilag AG, Merck (Schweiz) AG and sanofi-aventis (suisse) sa. The Swiss Group for Clinical Cancer Research (Schweizerische Arbeitsgemeinschaft für Klinische Krebsforschung SAKK) is organizer of the Swiss PostASCO event.

The content of the presentations reflects speaker's positions. The content of the website is subject of the Chair's responsibility. Partners will not influence any of the content.

Off label use of products might be discussed. Please consult the prescribing information of the products mentioned (www.documed.ch).